A case study of publication bias in an influential series of reviews of drug education

References

• Tobler N. Meta-analysis of 143 adolescent drug prevention programs: quantitative outcome results of program participants compare to a control or comparison group. J Drug Issues 1986; 16: 537–567
   Web of Science ®Google Scholar
• Tobler N, Stratton H. Effectiveness of school-based drug prevention programs: a meta-analysis of the research. J Primary Prev 1997; 18: 71–128
   Google Scholar
• Tobler N, Roona M R, Ochshorn P, Marshall D G, Streke A V, Stackpole K M. School-based adolescent drug prevention programs: 1998 meta-analysis. J Primary Prev 2000; 20: 275–336
   Google Scholar
• Tobler N, Lessard T, Marshall D, Ochshorn P, Roona M. Effectiveness of school-based drug prevention programs for marijuana use. J Primary Prev 1997; 18: 71–128
   Google Scholar
• Black D R, Tobler N S, Sciacca J P. Peer helping/involvement: an efficacious way to meet the challenge of reducing alcohol, tobacco, and other drug use among youth?. J School Health 1998; 68: 87–93
   PubMed Web of Science ®Google Scholar
• Roona M R, Streke A V, Ochshorn P, Marshall D M, Palmer A P. Identifying effective school-based substance abuse prevention interventions. Background paper for Prevention 2000 Summit. Social Capital Development Corporation, Albany, NY 2000, http://silvergategroup.com/prev2000/papers.jsp (accessed 11 May 2007)
   Google Scholar
• Roona M R, Streke A V, Marshall D G. Substances, adolescence (meta-analysis). Encyclopedia of primary prevention and health promotion, T P Gullotta, M Bloom. Kluwer Academic/Plenum Publishers, New York 2003
   Google Scholar
• Streke A V, Roona M R, Marshall D G. substances, childhood (meta-analysis). Encyclopedia of primary prevention and health promotion, T P Gullotta, M Bloom. Kluwer Academic/Plenum Publishers, New York 2003
   Google Scholar
• Robert Wood Johnson Foundation, Princeton: RWJF, 2007. Available at: www.rwjf.org/reports/grr/040928.html (accessed 11 May 2007)
   Google Scholar
• Faggiano F, Vigna-Taglianti F D, Versino E, Zambon A, Borraccino A, Lemma P. School-based prevention for illicit drugs' use. Cochrane Database Syst Rev 2005, Issue 2, Art. no.: CD003020. DOI: 10.1002/14651858.CD003020.pub2
   PubMed Web of Science ®Google Scholar
• Loxley W, Toumbourou J W, Stockwell T, et al. The prevention of substance use, risk and harm in Australia: a review of the evidence. The National Drug Research Institute and the Centre for Adolescent Health, Ministerial Council on Drugs Strategy, Canberra 2004
   Google Scholar
• National Advisory Committee on Drugs. Drug use prevention: an overview of research. The Stationery Office, Dublin 2001
   Google Scholar
• Qualifications and Curriculum Authority. Drug, alcohol and tobacco education curriculum guidance for schools at key stages 1 – 4: teacher's booklet. Qualifications and Curriculum Authority, London 2003
   Google Scholar
• Dickersin K. The existence of publication bias and risk factors for its occurrence. JAMA 1990; 206: 1385–1389
   Google Scholar
• Rosenthal R. The ‘file drawer problem’ and tolerance for null results. Psychol Bull 1979; 86: 638–641
   Web of Science ®Google Scholar
• Thomas R, Perera R. School-based programmes for preventing smoking. Cochrane Database Syst Rev 2006, 3, Art. no.: CD001293. DOI: 10.1002/14651858.CD001293.pub2
   Google Scholar
• Foxcroft D R, Ireland D, Lowe G, Breen R. Primary prevention for alcohol misuse in young people. Cochrane Database Syst Rev 200, 3, Art. no.: CD003024. DOI: 10.1002/14651858.CD003024
   Google Scholar
• Gorman D M. Drug and violence prevention: rediscovering the critical rational dimension of evaluation research. J Exp Criminol 2005; 1: 39–62
   Google Scholar
• Skara S, Sussman S. A review of 25 long-term adolescent tobacco and other drug use prevention program evaluations. Prev Med 2003; 37: 451–474
   PubMed Web of Science ®Google Scholar
• Advisory Council on the Misuse of Drugs (AMCD). Pathways to problems. Hazardous use of tobacco, alcohol and other drugs by young people in the UK and its implications for policy. ACMD, London 2006
   Google Scholar
• Calnan M, Davey Smith G, Sterne J AC. The publication process itself was the major cause of publication bias in genetic epidemiology. J Clin Epidemiol 2006; 59: 1312–1318
   PubMed Web of Science ®Google Scholar
• Brown J H. Youth, drugs and resilience education. J Drug Educ 2001; 31: 83–122
   PubMed Web of Science ®Google Scholar
• DuPont R L. Implications for prevention policy: a commentary. Cost – benefit/cost-effectiveness research of drug abuse prevention: implications for programming and policy. NIDA Monograph 176, W J Bukoski, R I Evans. NIDA, Rockville, MD 1998
   Google Scholar
• Miller P, Moore D, Strang J. The regulation of research by funding bodies: an emerging ethical issue for the alcohol and other drug sector?. Int J Drug Policy 2006; 17: 12–16
   Google Scholar
• Gandi A G, Murphy-Graham E, Petrosino A, Chrismer S S, Weiss C H. The devil is in the details: examining the evidence for ‘proven’ school-based drug abuse prevention program. Eval Rev 2007; 31: 43–74
   PubMed Web of Science ®Google Scholar
• Hallfors D, Cho H, Sanchez V, Khatapoush S, Kim H M, Bauer D. Efficacy vs effectiveness trial results of an indicated ‘model’ substance abuse program: implications for public health. Am J Public Health 2006; 96: 2254–2259
   PubMed Web of Science ®Google Scholar
• Chalmers I. Underreporting research is scientific misconduct. JAMA 1990; 263: 1405–1408
   PubMed Web of Science ®Google Scholar
• Song F, Eastwood A J, Gilbody S, Duley L, Sutton A J. Publication and related biases. Health Technol Assess 2000; 4: 10
   Google Scholar
• Altman D G. Poor-quality medical research: what can journals do?. JAMA 2002; 287: 2765–2767
   PubMed Web of Science ®Google Scholar
• Decullier E, Lhéritier V, Chapuis F. Fate of biomedical research protocols and cohort publication bias in France: retrospective study. BMJ 2005; 331: 19–24
   Google Scholar
• Koren G, Shear H, Graham K, Einarson T. Bias against the null hypothesis: the reproductive hazards of cocaine. Lancet 1989; ii: 1440–1442
   Google Scholar